Stratrix
On the Record · Innospec

Innospec acquisitions, on the record

The businesses Innospec bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
QGP Química Geral ("QGP")
Word for word“The Company purchased the business for a total consideration of $ 58.0 million, net of cash acquired, and subject to working capital adjustments.” 10-K for 2023
acquisition—a total consideration of $ 58.0 million, net of cash acquired, and subject to working capital adjustments
QGP Química Geral
Word for word“On December 8, 2023, the Company acquired QGP Química Geral (“QGP”).” 10-K for 2025
acquisitionDecember 8, 2023—
Biotechnology Solutions LLC
Word for word“On July 31, 2025 the Company completed the acquisition of the trade and net assets of Biotechnology Solutions LLC.” 10-K for 2025
acquisitionJuly 31, 2025—
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2016-12-31$197.4 million$107.4 million
2017-12-31−$2.6 million—
2018-12-31$5.4 million$7.5 million
2019-12-31$0—
2020-12-31$0—
2021-12-31$0—
2022-12-31$0—
2023-12-31$34.7 million$37.4 million
2024-12-31$200,000—
2025-12-31$700,000$2 million

Deal filings since 2016

Read from Innospec’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.